Inhibitory effect of combinations of digoxin and endogenous cardiotonic steroids on Na+/K+-ATPase activity in human kidney membrane preparation

Life Sciences

Volumn 88, Issue 1-2, 2011, Pages 39-42

  Touza, Natália Araújo ^a   Pôças, Elisa Suzana Carneiro ^a,b   Quintas, Luis Eduardo M ^a   Cunha Filho, Geraldino ^c   Santos, Maria Lucília ^c   Noël, François ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b INSTITUTO FEDERAL DE EDUCAÇÃO   (Brazil)

^c UNIVERSITY OF BRASILIA   (Brazil)

Author keywords

ATPase; Bufadienolides; Combination; Digoxin; Marinobufagenin; Marinobufagin; Na K; Ouabain; Telocinobufagin

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); CARDIAC GLYCOSIDE; DIGOXIN; MARINOBUFAGENIN; OUABAIN; TELOCINOBUFAGIN; UNCLASSIFIED DRUG;

ARTICLE; DRUG POTENTIATION; ENZYME ACTIVITY; ENZYME INHIBITION; HUMAN; HUMAN TISSUE; KIDNEY;

BUFANOLIDES; CARDIAC GLYCOSIDES; CELL MEMBRANE; DIGOXIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; HUMANS; INHIBITORY CONCENTRATION 50; ISOENZYMES; KIDNEY; OUABAIN; SODIUM-POTASSIUM-EXCHANGING ATPASE;

MAMMALIA; STROPHANTHUS GRATUS;

EID: 78650521807     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2010.10.027     Document Type: Article

References (45)

1. A. Ahmed Digoxin and reduction in mortality and hospitalization in geriatric heart failure: importance of low doses and low serum concentrations J Gerontol Med Sci 62A 3 2007 323 329
2. A. Ahmed, I.B. Aban, M.T. Weaver, W.S. Aronow, and J.L. Fleg Serum digoxin concentration and outcomes in women with heart failure: a bi-directional effect and a possible effect modification by ejection fraction Eur J Heart Fail 8 4 2006 409 419
3. A. Ahmed, G. Gambassi, M.T. Weaver, J.B. Young, W.H. Wehrmacher, and M.W. Rich Effects of discontinuation of digoxin versus continuation at low serum digoxin concentrations in chronic heart failure Am J Cardiol 100 2 2007 280 284
4. A. Aperia New roles for an old enzyme: Na, K-ATPase emerges as an interesting drug target J Intern Med 261 1 2007 44 52
5. A.Y. Bagrov, O.V. Fedorova, R.I. Dmitrieva, W.N. Howald, A.P. Hunter, and E.A. Kuznetsova Characterization of a urinary bufodienolide Na+, K+-ATPase inhibitor in patients after acute myocardial infarction Hypertension 31 5 1998 1097 1103
6. A.Y. Bagrov, J.I. Shapiro, and O.V. Fedorova Endogenous cardiotonic steroids: physiology, pharmacology, and novel therapeutic targets Pharmacol Rev 61 2009 9 38
7. A.Y. Bagrov, and J.I. Shapiro Endogenous digitalis: pathophysiologic roles and therapeutic applications Nat Clin Pract Nephrol 4 7 2008 378 392
8. A. Bell Antimalarial drug synergism and antagonism: mechanistic and clinical significance FEMS Microbiol Lett 253 2005 171 184
9. H. Bundgaard, and K. Kjeldsen Human myocardial Na, K-ATPase concentration in heart failure Mol Cell Biochem 163 1996 277 283
10. G. Crambert, U. Hasler, A.T. Beggah, C. Yu, N.N. Modyanov, and J.D. Horisberger Transport and pharmacological properties of nine different human Na, K-ATPase isozymes J Biol Chem 275 3 2000 1976 1986
11. G.A. Cunha-Filho, I.S. Resck, B.C. Cavalcanti, C.Ó. Pessoa, M.O. Moraes, J.R.O. Ferreira, F.A.R. Rodrigues, and M.L. dos Santos Cytotoxic profile of natural and some modified bufadienolides from toad Rhinella schneideri parotoid gland secretion Toxicon 56 3 2010 339 348
12. J.W. Daly, N. Noimai, B. Kongkathip, N. Kongkathip, J.M. Wilham, and H.M. Garraffo Biologically active substances from amphibians: preliminary studies on anurans from twenty-one genera of Thailand Toxicon 44 8 2004 805 815
13. Digitalis Investigation Group The effect of digoxin on mortality and morbidity in patients with heart failure N Engl J Med 336 1997 525 533
14. T. Eisner, D.F. Wiemer, L.W. Haynes, and J. Meinwald Defense mechanisms of arthropods. 59. Lucibufagins: defensive steroids from the fireflies Photinus ignitus and P. marginellus (Coleoptera: Lampyridae) Proc Natl Acad Sci USA 75 2 1978 905 908
15. M. Ferrandi, P. Barassi, I. Molinari, L. Torielli, G. Tripodi, and E. Minotti Ouabain antagonists as antihypertensive agents Curr Pharm Des 11 25 2005 3301 3305
16. C.H. Fiske, and Y. Subbarow The colorimetric determination of phosphorus J Biol Chem 66 1925 375 392
17. J. Flier, M.W. Edwards, J.W. Daly, and C.W. Myers Widespread occurrence in frogs and toads of skin compounds interacting with the ouabain site of Na+, K+-ATPase Science 208 4443 1980 503 505
18. M. Gheorghiade Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial Eur Heart J 27 2 2006 178 186
19. J.M. Hamlyn, M.P. Blaustein, S. Bova, D.W. Du Charme, D.W. Harris, and F. Mandel Identification and characterization of a ouabain-like compound from human plasma Proc Natl Acad Sci USA 88 1991 6259 6263
20. J.M. Hamlyn, and P. Manunta Ouabain, digitalis-like factors and hypertension J Hypertens Suppl 10 7 1992 S99 S111
21. C. Hauck, T. Potter, M. Bartz, T. Wittwer, T. Wahlers, and U. Mehlhorn Isoform specificity of cardiac glycosides binding to human Na+, K+-ATPase α1β1, α2β1 and α3β1 Eur J Pharmacol 622 1-3 2009 7 14
22. P.J. Hauptman, and R.A. Kelly Digitalis Circulation 99 9 1999 1265 1270
23. D.A. Hutchinson, A. Mori, A.H. Savitzky, G.M. Burghardt, X. Wu, and J. Meinwald Dietary sequestration of defensive steroids in nuchal glands of the Asian snake Rhabdophis tigrinus Proc Natl Acad Sci USA 104 7 2007 2265 2270
24. S.A. Jortani, S.D. Prabhu, and R. Valdes Jr. Strategies for developing biomarkers of heart failure Clin Chem 50 2 2004 265 278
25. A. Katz, Y. Lifshitz, E. Bab-Dinitz, E. Kapri-Pardes, R. Goldshleger, D.M. Tal, and S.J.D. Karlish Selectivity of digitalis glycosides for isoforms of human Na, K-ATPase J Biol Chem 285 25 2010 19582 19592
26. Y. Komiyama, X.H. Dong, N. Nishimura, H. Masaki, M. Yoshika, and M. Masuda A novel endogenous digitalis, telocinobufagin, exhibits elevated plasma levels in patients with terminal renal failure Clin Biochem 38 1 2005 36 45
27. D. Lichtstein, I. Gati, S. Samuelov, D. Berson, Y. Rozenman, and L. Landau Identification of digitalis-like compounds in human cataractous lenses Eur J Biochem 216 1 1993 261 268
28. +-ATPase expression: isoform- and tissue-dependency. Comparative Biochemistry and Physiology A Mol Integr Physiol 131 2 2002 323 333
29. O.H. Lowry, N.J. Rosebrough, A.L. Farr, and R.J. Randall Protein measurement with the folin phenol reagent J Biol Chem 193 1951 265 275
30. P. Manunta, and M. Ferrandi Cardiac glycosides and cardiomyopathy Hypertension 47 2006 343 344
31. A.A. McDonough, J. Wang, and R.A. Farley Significance of sodium pump isoforms in digitalis therapy J Mol Cell Cardiol 27 4 1995 1001 1009
32. T. Mijatovic, E. Van Quaquebeke, B. Delest, O. Debeir, F. Darro, and R. Kiss Cardiotonic steroids on the road to anti-cancer therapy Biochim Biophys Acta 1776 1 2007 32 57
33. M. Nesher, U. Shpolansky, H. Rosen, and D. Lichtstein The digitalis-like steroid hormones: new mechanisms of action and biological significance Life Sci 80 2007 2093 2107
34. M.G. Nicholls, L.K. Lewis, T.G. Yandle, G. Lord, W. McKinnon, and P.J. Hilton Ouabain, a circulating hormone secreted by the adrenals, is pivotal in cardiovascular disease. Fact or fantasy? J Hypertens 27 1 2009 3 8
35. S.V. Pierre, and Z. Xie The Na, K-ATPase receptor complex: its organization and membership Cell Biochem Biophys 46 2006 303 316
36. E.S.C. Pôças, N.A. Touza, A.J.M. da Silva, P.R.R. Costa, and F. Noël Synergistic interaction between ouabain and 8-methoxy-3, 9-dihydroxy coumestan, a non-steroidal synthetic inhibitor of Na+, K+-ATPase Life Sci 81 2007 1199 1204
37. +-ATPase density is sexually dimorphic in the adult rat kidney Ann NY Acad Sci 834 1997 552 554
38. S.S. Rathore, J.P. Curtis, Y. Wang, M.R. Bristow, and H.M. Krumholz Association of serumdigoxin concentration and outcomes in patients with heart failure J Am Med Assoc 289 7 2003 871 878 (Pubitemid 37430346)
39. K. Repke, and H.J. Portius Über die identität der ionenpumpen-ATPase in der zellmembran des herzskels mit einem digitalis rezeptorenzym Experientia 19 1963 452 458
40. W. Schoner, and G. Scheiner-Bobis Endogenous and exogenous cardiac glycosides and their mechanisms of action Am J Cardiovasc Drugs 7 3 2007 173 189
41. R.H. Schwinger, J. Wang, K. Frank, J. Müller-Ehmsen, K. Brixius, and A.A. McDonough Reduced sodium pump α1, α3, and β1-isoform protein levels and Na+, K+-ATPase activity but unchanged Na+-Ca2+ exchanger protein levels in human heart failure Circulation 99 16 1999 2105 2112
42. P.S. Steyn, and F.V. Heerden Bufadienolides of plant and animals origin Nat Prod Rep 15 4 1998 397 413
43. R.J. Tallarida, D.J. Stone Jr., and R.B. Raffa Efficient designs for studying synergistic drug combinations Life Sci 61 26 1997 417 425
44. A.G. Therien, and R. Blostein Mechanisms of sodium pump regulation Am J Physiol Cell Physiol 279 3 2000 C541 C566
45. +-ATPase as a signal transducer Eur J Biochem 269 2002 2434 2439